(Q39534055)

12 September 2017

1 reference

title

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use. (English)

1 reference

12 September 2017

0 references

1 reference

J H Paton

1

1 reference

12 September 2017

D S Reeves

series ordinal

2

1 reference

12 September 2017

1 August 1988

1 reference

12 September 2017

1 reference

12 September 2017

36

1 reference

12 September 2017

2

1 reference

12 September 2017

193-228

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198836020-00004

12 September 2017

0 references

cites work

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

1 reference

12 December 2020

Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains

1 reference

12 December 2020

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

1 reference

12 December 2020

Ciprofloxacin-resistant Pseudomonas.

1 reference

12 December 2020

The antimicrobial spectrum of norfloxacin

1 reference

12 December 2020

Single doses of ofloxacin in uncomplicated gonorrhoea

1 reference

12 December 2020

Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations

1 reference

12 December 2020

Penetration of enoxacin into bronchial secretions

1 reference

12 December 2020

Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones

1 reference

12 December 2020

Norfloxacin penetration into human renal and prostatic tissues

1 reference

12 December 2020

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

1 reference

12 December 2020

Penetration of ofloxacin into bronchial secretions

1 reference

12 December 2020

Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study

1 reference

12 December 2020

A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

1 reference

12 December 2020

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

1 reference

12 December 2020

Ciprofloxacin for soft tissue infections.

1 reference

12 December 2020

Ciprofloxacin: comparative data in cystic fibrosis

1 reference

12 December 2020

Ciprofloxacin-resistant staphylococci

1 reference

12 December 2020

Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

12 December 2020

Treatment of chronic salmonella carriers with ciprofloxacin

1 reference

12 December 2020

Quinolone/ureidopenicillin cross-resistance

1 reference

12 December 2020

The comparative pharmacokinetics of five quinolones

1 reference

12 December 2020

Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland

1 reference

12 December 2020

Treatment of Penicillin-ResistantNeisseria gonorrhoeaewith Oral Norfloxacin

1 reference

12 December 2020

Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results

1 reference

12 December 2020

Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of ciprofloxacin

1 reference

12 December 2020

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound

1 reference

12 December 2020

Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis

1 reference

12 December 2020

Enoxacin concentration in human prostatic tissue after oral administration

1 reference

12 December 2020

Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women

1 reference

12 December 2020

Comparative in-vitro activity of ciprofloxacin against non-fermenters.

1 reference

12 December 2020

Ciprofloxacin therapy in cystic fibrosis

1 reference

12 December 2020

Bismuth/ofloxacin combination for duodenal ulcer

1 reference

12 December 2020

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

1 reference

12 December 2020

Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

1 reference

12 December 2020

Norfloxacin disposition after sequentially increasing oral doses

1 reference

12 December 2020

Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria

1 reference

12 December 2020

Norfloxacin for prevention of bacterial infections in granulocytopenic patients

1 reference

12 December 2020

Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin

1 reference

12 December 2020

The SOS regulatory system of Escherichia coli

1 reference

12 December 2020

Ciprofloxacin in the treatment of gonorrhoea and non-gonococcal urethritis

1 reference

12 December 2020

Efficacy and safety of pefloxacin in the treatment of patients with complicated urinary tract infections

1 reference

12 December 2020

Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin

1 reference

12 December 2020

Arthropathy in a patient with cystic fibrosis taking ciprofloxacin

1 reference

12 December 2020

Nalidixic acid and bacterial chromosome replication

1 reference

12 December 2020

Pefloxacin in acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin

1 reference

12 December 2020

In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae

1 reference

12 December 2020

Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan.

1 reference

12 December 2020

Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients

1 reference

12 December 2020

Corynebacterium jeikeium (group JK) resistance to ciprofloxacin emerging during therapy

1 reference

12 December 2020

Dose ranging study and constant infusion evaluation of ciprofloxacin

1 reference

12 December 2020

Use of norfloxacin in the treatment of acute diarrheal disease

1 reference

12 December 2020

Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents

1 reference

12 December 2020

The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection.

1 reference

12 December 2020

A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients

1 reference

12 December 2020

Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections

1 reference

12 December 2020

Worldwide clinical data on efficacy and safety of ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin treatment of Staphylococcus aureus infections.

1 reference

12 December 2020

Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

1 reference

12 December 2020

The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

1 reference

12 December 2020

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

1 reference

12 December 2020

Open randomised comparison of ofloxacin and norfloxacin in the treatment of complicated urinary tract infections

1 reference

12 December 2020

Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria

1 reference

12 December 2020

Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis.

1 reference

12 December 2020

Reduced enteral absorption of ciprofloxacin in the presence of antacids

1 reference

12 December 2020

In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

In-vitro activity of newer quinolones against aerobic bacteria.

1 reference

12 December 2020

Effect of dose size on bioavailability of ciprofloxacin

1 reference

12 December 2020

Effect of food on enoxacin absorption

1 reference

12 December 2020

Diffusion of ofloxacin into human lung tissue

1 reference

12 December 2020

Resistance to ciprofloxacin.

1 reference

12 December 2020

In vitro activity of ciprofloxacin against Brucella melitensis

1 reference

12 December 2020

Bacterial mutagenicity and the 4-quinolones

1 reference

12 December 2020

Overview of clinical experience with ciprofloxacin

1 reference

12 December 2020

Activities of newer quinolones against Legionella group organisms

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

1 reference

12 December 2020

Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans

1 reference

12 December 2020

In vitro activity of ciprofloxacin combined with azlocillin

1 reference

12 December 2020

The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi

1 reference

12 December 2020

Site-specific cleavage of DNA by E. coli DNA gyrase

1 reference

12 December 2020

Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males

1 reference

12 December 2020

Overview of preclinical studies with ciprofloxacin

1 reference

12 December 2020

The pharmacokinetics of ofloxacin in healthy adult male volunteers

1 reference

12 December 2020

An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.

1 reference

12 December 2020

The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.

1 reference

12 December 2020

Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.

1 reference

12 December 2020

Efficacy and tolerance of oral ofloxacin in treating various infections.

1 reference

12 December 2020

Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study.

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in healthy volunteers and patients with impaired kidney function.

1 reference

12 December 2020

Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens

1 reference

12 December 2020

Comparative studies of enoxacin and amoxicillin for acute uncomplicated cystitis in women

1 reference

12 December 2020

Enoxacin-warfarin interaction: pharmacokinetic and stereochemical aspects

1 reference

12 December 2020

Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization

1 reference

12 December 2020

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

1 reference

12 December 2020

Interaction between ciprofloxacin and vancomycin against staphylococci

1 reference

12 December 2020

In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.

1 reference

12 December 2020

The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts

1 reference

12 December 2020

A review of urinary tract infection in the elderly

1 reference

12 December 2020

[In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections]

1 reference

12 December 2020

The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers

1 reference

12 December 2020

Comparison of ciprofloxacin and rifampicin in experimental Legionella pneumophila pneumonia

1 reference

12 December 2020

Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin.

1 reference

12 December 2020

The influence of quinolone derivatives on theophylline clearance

1 reference

12 December 2020

Ciprofloxacin (4-quinolone) and Mycobacterium leprae

1 reference

12 December 2020

Single dose ciprofloxacin for treating gonococcal infections in men.

1 reference

12 December 2020

Treatment of chancroid with ciprofloxacin. A prospective, randomized clinical trial.

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.

1 reference

12 December 2020

Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study

1 reference

12 December 2020

Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides

1 reference

12 December 2020

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

1 reference

12 December 2020

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Penetration of ofloxacin from blood to sputum

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 December 2020

The pharmacokinetics of ciprofloxacin in patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

1 reference

12 December 2020

In-vitro susceptibility of mycobacteria to ciprofloxacin.

1 reference

12 December 2020

Penetration of ciprofloxacin into cerebrospinal fluid

1 reference

12 December 2020

In vitro activity of ciprofloxacin against gram-positive cocci.

1 reference

12 December 2020

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Nalidixic Acid: an Antibacterial Paradox

1 reference

12 December 2020

Ciprofloxacin-resistant Staphylococcus aureus

1 reference

12 December 2020

Enoxacin decreases the clearance of theophylline in man.

1 reference

12 December 2020

Animal models: the in-vivo evaluation of ciprofloxacin

1 reference

12 December 2020

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

1 reference

12 December 2020

Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.

1 reference

12 December 2020

In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives

1 reference

12 December 2020

Bactericidal intraprostatic concentrations of norfloxacin

1 reference

12 December 2020

Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients

1 reference

12 December 2020

The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.

1 reference

12 December 2020

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

12 December 2020

In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function

1 reference

12 December 2020

Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis

1 reference

12 December 2020

Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study

1 reference

12 December 2020

Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.

1 reference

12 December 2020

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antibacterial 4-quinolones

1 reference

12 December 2020

A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure

1 reference

12 December 2020

Development of resistance to ofloxacin

1 reference

12 December 2020

In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.

1 reference

12 December 2020

Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

1 reference

12 December 2020

Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.

1 reference

12 December 2020

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)

1 reference

12 December 2020

Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers

1 reference

12 December 2020

The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure

1 reference

12 December 2020

Pharmacokinetics of ofloxacin in patients on haemodialysis treatment

1 reference

12 December 2020

Pharmacokinetics and tolerance of enoxacin in healthy volunteers administered at a dosage of 400 mg twice daily for 14 days

1 reference

12 December 2020

New approaches to the treatment of urinary tract infection

1 reference

12 December 2020

Treatment of multiresistant Salmonella typhi with oral ciprofloxacin.

1 reference

12 December 2020

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

1 reference

12 December 2020

The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity

1 reference

12 December 2020

Ciprofloxacin in cystic fibrosis

1 reference

12 December 2020

Tissue penetration and metabolism of ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of norfloxacin in renal failure

1 reference

12 December 2020

In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis

1 reference

12 December 2020

Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.

1 reference

12 December 2020

Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity

1 reference

12 December 2020

Biliary tract excretion of ofloxacin in man.

1 reference

12 December 2020

Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function

1 reference

12 December 2020

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare

1 reference

12 December 2020

Antimycoplasmal activity of ofloxacin (DL-8280).

1 reference

12 December 2020

Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice

1 reference

12 December 2020

The effect of quinolone antibacterials on the gastrointestinal flora compared with that of other antibacterials

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

12 December 2020

The use of quinolones in respiratory tract infections

1 reference

12 December 2020

The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

12 December 2020

Oral ciprofloxacin in resistant urinary tract infections

1 reference

12 December 2020

Pefloxacin concentrations in human aqueous humour and lens

1 reference

12 December 2020

Susceptibility of Eikenella corrodens to newer and older quinolones

1 reference

12 December 2020

Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

1 reference

12 December 2020

Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections.

1 reference

12 December 2020

Ciprofloxacin: an overview of adverse experiences

1 reference

12 December 2020

A homogeneous type II DNA topoisomerase from HeLa cell nuclei

1 reference

12 December 2020

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

1 reference

12 December 2020

The effect of ciprofloxacin on methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Diffusion of enoxacin into the cerebrospinal fluid in dogs with healthy meninges and with experimental meningitis.

1 reference

12 December 2020

Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli

1 reference

12 December 2020

In vitro and in vivo activity of DL-8280, a new oxazine derivative

1 reference

12 December 2020

Dosage of intravenous ciprofloxacin

1 reference

12 December 2020

Norfloxacin--a review of pharmacology and tissue penetration

1 reference

12 December 2020

Clinical experience with ciprofloxacin in the USA.

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers

1 reference

12 December 2020

Side effects of ofloxacin in clinical trials and in postmarketing surveillance

1 reference

12 December 2020

Comparative in vitro studies with 4-quinolone antimicrobials

1 reference

12 December 2020

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

12 December 2020

Resistance of Neisseria gonorrhoeae to enoxacin.

1 reference

12 December 2020

Open, prospective study of the clinical efficacy of ciprofloxacin

1 reference

12 December 2020

In-vitro activity of pefloxacin compared with six other quinolones.

1 reference

12 December 2020

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

1 reference

12 December 2020

Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results

1 reference

12 December 2020

In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections

1 reference

12 December 2020

Biotransformation of selected gyrase inhibitors

1 reference

12 December 2020

Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis

1 reference

12 December 2020

Cleavage of DNA by mammalian DNA topoisomerase II

1 reference

12 December 2020

Treatment of skin and soft tissue infections with oral ciprofloxacin

1 reference

12 December 2020

The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin

1 reference

12 December 2020

Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy.

1 reference

12 December 2020

Penetration of pefloxacin in human heart valves.

1 reference

12 December 2020

The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after parenteral and oral administration

1 reference

12 December 2020

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea

1 reference

12 December 2020

Ciprofloxacin and co-trimoxazole in urinary tract infection

1 reference

12 December 2020

Interactions between twisted DNAs and enzymes: the effects of superhelical turns

1 reference

12 December 2020

Activities of new quinoline derivatives against genital pathogens

1 reference

12 December 2020

The diffusion of pefloxacin into bone and the treatment of osteomyelitis

1 reference

12 December 2020

Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens

1 reference

12 December 2020

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid

1 reference

12 December 2020

In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid

1 reference

12 December 2020

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

1 reference

12 December 2020

DNA gyrase: an enzyme that introduces superhelical turns into DNA

1 reference

12 December 2020

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin

1 reference

12 December 2020

Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

1 reference

12 December 2020

In-vitro sensitivity of legionellas, meningococci and mycoplasmas to ciprofloxacin and enoxacin

1 reference

12 December 2020

Treatment of respiratory tract infections with ciprofloxacin

1 reference

12 December 2020

The new quinolones and their combinations with other agents for therapy of severe infections

1 reference

12 December 2020

Ciprofloxacin concentrations in bone and muscle after oral dosing

1 reference

12 December 2020

The inoculum effect with gram-negative bacteria in vitro and in vivo

1 reference

12 December 2020

Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Interaction between quinolones and caffeine

1 reference

12 December 2020

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

12 December 2020

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

1 reference

12 December 2020

10.2165/00003495-198836020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1009458709

0 references

Fatcat ID

release_poexuq7f55by3dugeooxguwrcm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/poexuq7f55by3dugeooxguwrcm

24 November 2022

mapped directly with Wikidata item

1 reference